Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-3,page-paged-3,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.7.0,vc_responsive

CLIENT NEWS

 

 

  • Marinomed Biotech AG signs new agreement for Carragelose in South Korea
    12 April 2022
    www.marinomed.com
  • RedHill Reports Potent Inhibition of Omicron with Oral COVID-19 Drug Candidate Opaganib In Vitro
    11 April 2022
    www.redhillbio.com
  • PEI Regulatory Approval Received for Government Funded (€ 7.4 Million) Clinical Trial Investigating Adrenomed’s Adrecizumab in Treating Endothelial Barrier Dysfunction in Hospitalized COVID-19 Patients
    11 April 2022
    www.adrenomed.com
  • MagForce AG: MagForce USA, Inc. receives Payment Code Approval by the American Medical Association for the Focal Ablation of Prostate Cancer with the NanoTherm Therapy System
    08 April 2022
    www.magforce.de
  • AiCuris nominates Madam Therapeutics with its innovative peptide approach to fight AMR as the first winner of the AiCubator Resident Status in 2022 at BIOCOM AMR Conference 2022
    08 April 2022
    www.aicuris.com
  • Andera Partners to sell its Life Sciences’ portfolio company ReViral to Pfizer
    07 April 2022
    www.anderapartners.com
  • iOmx to Present New Pre-Clinical Data on SIK3 Checkpoint Inhibitor OMX-0407 at AACR 2022
    07 April 2022
    www.iomx.com
  • Abivax reports excellent one-year efficacy and safety data of ABX464 phase 2b maintenance trial in ulcerative colitis
    06 April 2022
    www.abivax.com
  • ViGeneron signs gene therapy strategic collaboration and option agreement with Regeneron for one inherited retinal disease target
    06 April 2022
    www.vigeneron.com
  • Newron announces AGM 2022 results
    05 April 2022
    www.newron.com